CN Stock MarketDetailed Quotes

000513 Livzon Pharmaceutical Group Inc.

Watchlist
  • 38.18
  • -0.03-0.08%
Market Closed May 23 15:00 CST
35.42BMarket Cap17.89P/E (TTM)

Livzon Pharmaceutical Group Inc. Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-4.99%3.24B
-1.58%12.43B
1.76%9.65B
6.15%6.69B
-1.90%3.41B
4.69%12.63B
1.27%9.49B
1.08%6.3B
3.86%3.48B
14.67%12.06B
Operating revenue
-4.99%3.24B
-1.58%12.43B
1.76%9.65B
6.15%6.69B
-1.90%3.41B
4.69%12.63B
1.27%9.49B
1.08%6.3B
3.86%3.48B
14.67%12.06B
Other operating revenue
----
-1.36%104.45M
----
-10.54%56.21M
----
-22.07%105.89M
----
50.52%62.83M
----
136.99%135.88M
Total operating cost
-10.59%2.43B
-3.66%9.93B
1.43%7.67B
7.08%5.33B
-1.92%2.72B
2.95%10.31B
-1.14%7.56B
-0.73%4.98B
3.53%2.77B
20.39%10.01B
Operating cost
-9.10%1.15B
0.09%4.47B
6.42%3.48B
9.61%2.4B
7.03%1.26B
4.90%4.46B
2.16%3.27B
3.14%2.19B
4.88%1.18B
15.77%4.25B
Operating tax surcharges
-20.30%32.3M
3.45%151.52M
8.36%114.9M
17.23%78.87M
8.19%40.53M
6.58%146.47M
-1.42%106.03M
-5.21%67.27M
-7.23%37.46M
11.17%137.43M
Operating expense
-9.20%876.11M
-7.44%3.6B
-3.03%2.81B
3.35%1.97B
-12.80%964.91M
0.09%3.89B
-5.97%2.9B
-6.92%1.9B
-2.50%1.11B
26.27%3.88B
Administration expense
28.75%192.68M
-0.39%654.27M
-12.23%486.96M
-12.38%310.93M
-24.94%149.65M
-1.10%656.86M
13.81%554.79M
22.34%354.87M
16.94%199.38M
-0.02%664.18M
Financial expense
-522.72%-54.51M
-1.02%-271.5M
14.83%-216.48M
56.60%-41.45M
76.92%-8.75M
-283.72%-268.76M
-946.30%-254.17M
-281.83%-95.51M
-62.53%-37.93M
32.42%-70.04M
-Interest expense (Financial expense)
0.70%22.8M
4.65%102.09M
5.07%74.68M
2.67%48.69M
-3.44%22.64M
16.13%97.55M
0.21%71.07M
31.56%47.43M
66.68%23.45M
231.83%84M
-Interest Income (Financial expense)
-110.53%-76.02M
-16.82%-368.16M
-6.72%-271.99M
31.11%-68.71M
42.11%-36.11M
-94.30%-315.14M
-165.79%-254.87M
-53.12%-99.74M
-80.89%-62.38M
7.62%-162.19M
Research and development
-23.52%238.17M
-6.44%1.33B
0.72%985.76M
10.15%610.78M
8.00%311.41M
24.51%1.43B
24.48%978.75M
9.40%554.52M
24.56%288.33M
29.59%1.15B
Credit Impairment Loss
57.61%-5.65M
-129.72%-13.07M
-104.77%-18.67M
-562.83%-22.79M
-1,787.46%-13.32M
24.54%-5.69M
3.36%-9.12M
59.92%-3.44M
124.62%789.45K
-488.83%-7.54M
Asset Impairment Loss
-322.99%-4.1M
-165.85%-310.04M
10.17%-108.29M
-10.05%-29.97M
134.61%1.84M
-105.40%-116.62M
-239.25%-120.55M
4.82%-27.23M
76.72%-5.31M
21.44%-56.78M
Other net revenue
-15.87%36.48M
-367.80%-82.32M
101.26%699.9K
7,792.13%67.48M
173.24%43.36M
-85.86%30.74M
-136.27%-55.42M
-100.59%-877.3K
-41.98%15.87M
-27.06%217.36M
Fair value change income
105.96%1.55M
65.92%-25.65M
46.35%-41.99M
63.45%-32.45M
51.49%-25.95M
-226.89%-75.27M
-383.80%-78.27M
-355.14%-88.78M
-46.06%-53.5M
-361.47%-23.03M
Invest income
-58.41%15.72M
40.14%61.82M
28.10%50.76M
34.08%49.13M
73.44%37.8M
-50.78%44.11M
-42.28%39.63M
4.38%36.64M
29.47%21.8M
-39.29%89.62M
-Including: Investment income associates
3.36%13.91M
-4.48%58.46M
-7.29%47.38M
-0.45%37.02M
-10.72%13.46M
56.67%61.2M
118.83%51.1M
523.48%37.18M
529.98%15.08M
1,948.07%39.06M
Asset deal income
--306.57K
-119.80%-170.44K
-117.81%-199.73K
35.71%-328.23K
----
-87.77%860.66K
18.83%1.12M
-260.99%-510.52K
-1,788.99%-370.36K
755.98%7.03M
Other revenue
-33.37%28.65M
11.69%204.78M
6.55%119.09M
26.02%103.89M
-18.05%43M
-11.87%183.35M
-22.57%111.77M
-29.37%82.44M
-28.26%52.47M
-3.77%208.04M
Operating profit
14.98%848.89M
2.75%2.42B
6.12%1.99B
7.79%1.43B
2.04%738.29M
3.69%2.35B
-0.12%1.87B
-3.42%1.33B
3.30%723.5M
-9.34%2.27B
Add:Non operating Income
164.46%1.23M
-33.71%4.65M
-22.83%2.86M
-68.68%1.06M
-75.37%463.69K
1.89%7.02M
-17.85%3.7M
-10.43%3.4M
-70.11%1.88M
-15.96%6.89M
Less:Non operating expense
71.01%5.67M
37.28%37.09M
90.48%19.99M
2.48%6.13M
108.37%3.32M
-4.14%27.02M
-5.52%10.49M
26.60%5.98M
-43.50%1.59M
46.76%28.19M
Total profit
14.82%844.44M
2.24%2.38B
5.59%1.97B
7.62%1.42B
1.61%735.44M
3.78%2.33B
-0.13%1.87B
-3.54%1.32B
2.83%723.79M
-9.79%2.25B
Less:Income tax cost
5.58%128.36M
29.36%485.07M
13.19%345.79M
21.57%249.3M
7.91%121.58M
27.72%374.97M
19.42%305.49M
7.15%205.07M
6.19%112.67M
-18.02%293.59M
Net profit
16.65%716.08M
-2.96%1.9B
4.10%1.62B
5.06%1.17B
0.45%613.86M
0.18%1.96B
-3.24%1.56B
-5.28%1.12B
2.24%611.12M
-8.41%1.95B
Net profit from continuing operation
16.65%716.08M
-2.96%1.9B
4.10%1.62B
5.06%1.17B
0.45%613.86M
0.18%1.96B
-3.24%1.56B
-5.28%1.12B
2.24%611.12M
-8.41%1.95B
Less:Minority Profit
238.80%108.26M
-221.40%-56.05M
-57.47%22.77M
-60.48%39.5M
-44.75%31.95M
-73.83%46.17M
-66.50%53.53M
-14.79%99.96M
-25.96%57.83M
-57.63%176.42M
Net profit of parent company owners
4.45%607.82M
2.32%1.95B
6.29%1.6B
11.50%1.13B
5.17%581.91M
7.53%1.91B
3.72%1.51B
-4.23%1.02B
6.47%553.29M
3.54%1.78B
Earning per share
Basic earning per share
4.84%0.65
2.94%2.1
6.83%1.72
11.93%1.22
5.08%0.62
7.37%2.04
3.87%1.61
-4.39%1.09
5.36%0.59
3.83%1.9
Diluted earning per share
4.84%0.65
2.94%2.1
6.83%1.72
11.93%1.22
5.08%0.62
7.37%2.04
3.87%1.61
-4.39%1.09
7.27%0.59
3.83%1.9
Other composite income
65.23%-22.95M
-128.70%-37.11M
-149.90%-50.05M
-91.82%2.71M
-357.06%-66.01M
210.33%129.31M
163.56%100.29M
122.42%33.08M
88.34%-14.44M
-182.90%-117.2M
Other composite income of parent company owners
64.66%-23.16M
-127.88%-39.01M
-151.95%-50.71M
-93.77%1.98M
-361.82%-65.54M
213.37%139.94M
161.97%97.61M
121.70%31.87M
88.52%-14.19M
-185.97%-123.43M
Other composite income of minority owners
144.57%209.11K
117.82%1.89M
-75.47%659.05K
-40.00%720.93K
-87.36%-469.16K
-270.61%-10.63M
1,036.05%2.69M
282.00%1.2M
-2.59%-250.41K
383.99%6.23M
Total composite income
26.52%693.13M
-10.76%1.86B
-5.20%1.57B
2.28%1.18B
-8.18%547.85M
13.62%2.08B
14.15%1.66B
11.47%1.15B
25.92%596.68M
-19.26%1.83B
Total composite income of parent company owners
13.23%584.66M
-6.57%1.91B
-3.34%1.55B
8.30%1.14B
-4.22%516.37M
24.03%2.05B
23.87%1.6B
14.62%1.05B
36.14%539.1M
-11.10%1.65B
Total composite income of minority owners
244.51%108.46M
-252.39%-54.16M
-58.33%23.43M
-60.24%40.22M
-45.32%31.48M
-80.54%35.54M
-64.76%56.22M
-13.28%101.16M
-26.04%57.58M
-55.91%182.65M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -4.99%3.24B-1.58%12.43B1.76%9.65B6.15%6.69B-1.90%3.41B4.69%12.63B1.27%9.49B1.08%6.3B3.86%3.48B14.67%12.06B
Operating revenue -4.99%3.24B-1.58%12.43B1.76%9.65B6.15%6.69B-1.90%3.41B4.69%12.63B1.27%9.49B1.08%6.3B3.86%3.48B14.67%12.06B
Other operating revenue -----1.36%104.45M-----10.54%56.21M-----22.07%105.89M----50.52%62.83M----136.99%135.88M
Total operating cost -10.59%2.43B-3.66%9.93B1.43%7.67B7.08%5.33B-1.92%2.72B2.95%10.31B-1.14%7.56B-0.73%4.98B3.53%2.77B20.39%10.01B
Operating cost -9.10%1.15B0.09%4.47B6.42%3.48B9.61%2.4B7.03%1.26B4.90%4.46B2.16%3.27B3.14%2.19B4.88%1.18B15.77%4.25B
Operating tax surcharges -20.30%32.3M3.45%151.52M8.36%114.9M17.23%78.87M8.19%40.53M6.58%146.47M-1.42%106.03M-5.21%67.27M-7.23%37.46M11.17%137.43M
Operating expense -9.20%876.11M-7.44%3.6B-3.03%2.81B3.35%1.97B-12.80%964.91M0.09%3.89B-5.97%2.9B-6.92%1.9B-2.50%1.11B26.27%3.88B
Administration expense 28.75%192.68M-0.39%654.27M-12.23%486.96M-12.38%310.93M-24.94%149.65M-1.10%656.86M13.81%554.79M22.34%354.87M16.94%199.38M-0.02%664.18M
Financial expense -522.72%-54.51M-1.02%-271.5M14.83%-216.48M56.60%-41.45M76.92%-8.75M-283.72%-268.76M-946.30%-254.17M-281.83%-95.51M-62.53%-37.93M32.42%-70.04M
-Interest expense (Financial expense) 0.70%22.8M4.65%102.09M5.07%74.68M2.67%48.69M-3.44%22.64M16.13%97.55M0.21%71.07M31.56%47.43M66.68%23.45M231.83%84M
-Interest Income (Financial expense) -110.53%-76.02M-16.82%-368.16M-6.72%-271.99M31.11%-68.71M42.11%-36.11M-94.30%-315.14M-165.79%-254.87M-53.12%-99.74M-80.89%-62.38M7.62%-162.19M
Research and development -23.52%238.17M-6.44%1.33B0.72%985.76M10.15%610.78M8.00%311.41M24.51%1.43B24.48%978.75M9.40%554.52M24.56%288.33M29.59%1.15B
Credit Impairment Loss 57.61%-5.65M-129.72%-13.07M-104.77%-18.67M-562.83%-22.79M-1,787.46%-13.32M24.54%-5.69M3.36%-9.12M59.92%-3.44M124.62%789.45K-488.83%-7.54M
Asset Impairment Loss -322.99%-4.1M-165.85%-310.04M10.17%-108.29M-10.05%-29.97M134.61%1.84M-105.40%-116.62M-239.25%-120.55M4.82%-27.23M76.72%-5.31M21.44%-56.78M
Other net revenue -15.87%36.48M-367.80%-82.32M101.26%699.9K7,792.13%67.48M173.24%43.36M-85.86%30.74M-136.27%-55.42M-100.59%-877.3K-41.98%15.87M-27.06%217.36M
Fair value change income 105.96%1.55M65.92%-25.65M46.35%-41.99M63.45%-32.45M51.49%-25.95M-226.89%-75.27M-383.80%-78.27M-355.14%-88.78M-46.06%-53.5M-361.47%-23.03M
Invest income -58.41%15.72M40.14%61.82M28.10%50.76M34.08%49.13M73.44%37.8M-50.78%44.11M-42.28%39.63M4.38%36.64M29.47%21.8M-39.29%89.62M
-Including: Investment income associates 3.36%13.91M-4.48%58.46M-7.29%47.38M-0.45%37.02M-10.72%13.46M56.67%61.2M118.83%51.1M523.48%37.18M529.98%15.08M1,948.07%39.06M
Asset deal income --306.57K-119.80%-170.44K-117.81%-199.73K35.71%-328.23K-----87.77%860.66K18.83%1.12M-260.99%-510.52K-1,788.99%-370.36K755.98%7.03M
Other revenue -33.37%28.65M11.69%204.78M6.55%119.09M26.02%103.89M-18.05%43M-11.87%183.35M-22.57%111.77M-29.37%82.44M-28.26%52.47M-3.77%208.04M
Operating profit 14.98%848.89M2.75%2.42B6.12%1.99B7.79%1.43B2.04%738.29M3.69%2.35B-0.12%1.87B-3.42%1.33B3.30%723.5M-9.34%2.27B
Add:Non operating Income 164.46%1.23M-33.71%4.65M-22.83%2.86M-68.68%1.06M-75.37%463.69K1.89%7.02M-17.85%3.7M-10.43%3.4M-70.11%1.88M-15.96%6.89M
Less:Non operating expense 71.01%5.67M37.28%37.09M90.48%19.99M2.48%6.13M108.37%3.32M-4.14%27.02M-5.52%10.49M26.60%5.98M-43.50%1.59M46.76%28.19M
Total profit 14.82%844.44M2.24%2.38B5.59%1.97B7.62%1.42B1.61%735.44M3.78%2.33B-0.13%1.87B-3.54%1.32B2.83%723.79M-9.79%2.25B
Less:Income tax cost 5.58%128.36M29.36%485.07M13.19%345.79M21.57%249.3M7.91%121.58M27.72%374.97M19.42%305.49M7.15%205.07M6.19%112.67M-18.02%293.59M
Net profit 16.65%716.08M-2.96%1.9B4.10%1.62B5.06%1.17B0.45%613.86M0.18%1.96B-3.24%1.56B-5.28%1.12B2.24%611.12M-8.41%1.95B
Net profit from continuing operation 16.65%716.08M-2.96%1.9B4.10%1.62B5.06%1.17B0.45%613.86M0.18%1.96B-3.24%1.56B-5.28%1.12B2.24%611.12M-8.41%1.95B
Less:Minority Profit 238.80%108.26M-221.40%-56.05M-57.47%22.77M-60.48%39.5M-44.75%31.95M-73.83%46.17M-66.50%53.53M-14.79%99.96M-25.96%57.83M-57.63%176.42M
Net profit of parent company owners 4.45%607.82M2.32%1.95B6.29%1.6B11.50%1.13B5.17%581.91M7.53%1.91B3.72%1.51B-4.23%1.02B6.47%553.29M3.54%1.78B
Earning per share
Basic earning per share 4.84%0.652.94%2.16.83%1.7211.93%1.225.08%0.627.37%2.043.87%1.61-4.39%1.095.36%0.593.83%1.9
Diluted earning per share 4.84%0.652.94%2.16.83%1.7211.93%1.225.08%0.627.37%2.043.87%1.61-4.39%1.097.27%0.593.83%1.9
Other composite income 65.23%-22.95M-128.70%-37.11M-149.90%-50.05M-91.82%2.71M-357.06%-66.01M210.33%129.31M163.56%100.29M122.42%33.08M88.34%-14.44M-182.90%-117.2M
Other composite income of parent company owners 64.66%-23.16M-127.88%-39.01M-151.95%-50.71M-93.77%1.98M-361.82%-65.54M213.37%139.94M161.97%97.61M121.70%31.87M88.52%-14.19M-185.97%-123.43M
Other composite income of minority owners 144.57%209.11K117.82%1.89M-75.47%659.05K-40.00%720.93K-87.36%-469.16K-270.61%-10.63M1,036.05%2.69M282.00%1.2M-2.59%-250.41K383.99%6.23M
Total composite income 26.52%693.13M-10.76%1.86B-5.20%1.57B2.28%1.18B-8.18%547.85M13.62%2.08B14.15%1.66B11.47%1.15B25.92%596.68M-19.26%1.83B
Total composite income of parent company owners 13.23%584.66M-6.57%1.91B-3.34%1.55B8.30%1.14B-4.22%516.37M24.03%2.05B23.87%1.6B14.62%1.05B36.14%539.1M-11.10%1.65B
Total composite income of minority owners 244.51%108.46M-252.39%-54.16M-58.33%23.43M-60.24%40.22M-45.32%31.48M-80.54%35.54M-64.76%56.22M-13.28%101.16M-26.04%57.58M-55.91%182.65M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg